Main Article Content
Coronavirus Infection 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an emergency condition for global public health. Early detection of COVID-19 in pregnant women is needed. The neutrophil-to-lymphocyte ratio (NLR), as a marker of viral inflammatory response, is used to determine the presence of a viral or bacterial infection, both acute and chronic. The objective of this study was to determine the relationship between NLR and the polymerase chain reaction (PCR) swab test results in pregnant women with suspected coronavirus disease 2019.
A cross-sectional study was conducted on 9 pregnant women with suspected COVID-19. The subjects were inpatients at Moewardi Hospital Surakarta from 19 April-19 May 2020, who had rapid tests, complete blood examinations, and PCR swab tests. The NLR was categorized based on early warning scores according to research developed at Zhejiang University, with cut-off point 5.8. Diagnosis of COVID-19 was confirmed by PCR swab tests. Relation between NLR and PCR swab results was analyzed by the prevalence ratio.
Two patients (22.2%) had NLR >5.8, with positive swab results in both (100%). Seven patients with NLR <5.8 had positive swabs in only one (33.3%). The relationship between NLR and PCR swab test results showed a prevalence ratio of 0.143 (95% CI 0.023-0.877).
Pregnant women with NLR < 5.8 had a decreased risk of COVID-19. Routine blood examination is more suitable for finding pregnant women with suspected COVID-19.
The journal allows the authors to hold the copyright without restrictions and allow the authors to retain publishing rights without restrictions.
Dashraath P, Wong JLJ, Lim MXK, et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol 2020;222:521-31. http://doi.org/10.1016/j.ajog.2020.03.21.
Lapinsky SE. Acute respiratory failure in pregnancy. Obstet Med 2015;8:126-32. doi: 10.1177/1753495X15589223.
Qiao J. What are the risks of COVID-19 infection in pregnant women? Lancet 2020;395:760–2. https://doi.org/10.1016/S0140-6736(20)30365-2.
Hantoushzadeh S, Shamshirsaz AA, Aleyasin A, et al. Maternal death due to COVID-19. Am J Obstet Gynecol 2020;20:30516-20. doi: 10.1016/j.ajog.2020.04.030.
Mor G, Cardenas I, Abrahams V, Guller S. Inflammation and pregnancy: the role of the immune system at the implantation site. Ann N Y Acad Sci 2011;1221:80–7. doi: 10.1111/j.1749-6632.2010.05938.x.
Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, Ruiz C, Melguizo-Rodríguez L. SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev 2020;20:30109-X. http://doi.org/10.1016/j.cytogfr.2020.06.001.
Liu H, Wang LL, Zhao SJ, Kwak-Kim J, Mor G, Liao AH. Why are pregnant women susceptible to COVID-19? An immunological viewpoint. J Reprod Immunol 2020;139:103122. doi:10.1016/j.jri.2020.103122.
Hai L, Hu ZD. The clinical utility of neutrophil to lymphocyte ratio in pregnancy related complications: a mini-review. J Lab Precis Med 2020;5:1. doi: 10.21037/jlpm.2019.10.03.
Song CY, Xu J, He JQ, Lu YQ. Covid 19 early warning score: a multiparameter screening tool to identify highly suspected patients. medRxiv 2020;1–22. https://doi.org/10.1101/2020.03.05.20031906.
Arif SK, Muchtar F. Buku pedoman penanganan pasien kritis covid 19. Makasar : Perhimpunan Dokter Anestesi dan Terapi Intensif (Perdatin); 2020.
Liu Y, Du X, Chen J, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect 2020;81:e6-e12. Https://doi.org/10.1016/jinf.2020.04.002.
Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol 2017;39:529–39. https://doi.org/10.1007/s00281-017-0629-x
Min CK, Cheon S, Ha NY, et al. Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity. Sci Rep 2016; 6: 25359.https://doi.org/10.1038/srep25359.
Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis 2020;ciaa248. https://doi.org/10.1093/cid/ciaa248
Lou M, Luo P, Tang R, et al. Relationship between neutrophil-lymphocyte ratio and insulin resistance in newly diagnosed type 2 diabetes mellitus patients. BMC Endocr Disord 2015;15:9.
Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission. Lancet 2020; 395: 809–15. https://doi.org/10.1016/S0140-6736(20)30360-3.
Pokja Infeksi Saluran Reproduksi Perkumpulan Obstetri Dan Ginekologi Indonesia Tahun 2020 . Rekomendasi penanganan infeksi virus corona (COVID-19) pada maternal (hamil, bersalin dan nifas). Surabaya: POGI; 2020.
Yang H, Sun G, Tang F, et al. Clinical features and outcomes of pregnant women suspected of coronavirus disease 2019. J Infection 2020;81:e40–e4. https://doi.org/10.1016/j.jinf.2020.04.003.
Pereira A, Cruz-Melguizo S, Adrien M, Fuentes L, Marin E, Perez-Medina T. Clinical course of coronavirus disease-2019 in pregnancy. Acta Obstet Gynecol Scand 2020; 99:839–47. https://doi.org/10.1111/aogs.1392119.
Zaigham M, Andersson O. Maternal and perinatal outcomes with COVID-19: a systematic review of 108 pregnancies. Acta Obstet Gynecol Scand 2020;99:823-9. https://doi.org/10.1111/aogs.13867.
Cérbulo-Vázquez A, Figueroa-Damián R, Arriaga-Pizano LA, et al. Pregnant women infected with pandemic H1N1pdm2009 influenza virus displayed overproduction of peripheral blood CD69+ lymphocytes and increased levels of serum cytokines. PLoS ONE 2014;9: e107900. doi:10.1371/journal.pone.0107900.
Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323: 1061-69. http://doi.org/10.1001/jama.2020.1585.
Luo Y, Xie Y, Zhang W, et al. Combination of lymphocyte number and function in evaluating host immunity. Aging (Albany NY) 2019; 11:12685–707. doi: 10.18632/aging.102595.
Almeida MQ,Mendonca BB. Adrenal insufficiency and glucocorticoid use during the COVID-19 pandemic. Clinics. 2020;75:e2022. DOI: 10.6061/clinics/2020/e2022.